CN Patent
CN113717200B — 一种巴洛沙韦中间体的制备方法
Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2022-11-22 · 3y expired
What this patent protects
本发明提供一种巴洛沙韦中间体的制备方法。本发明使用有机醇镁和氯化镁作为反应试剂,以固体形式、稳定的醇镁试剂替换现有技术中液体形式的、易失活、易燃的格氏试剂,在保证反应的效率及产品纯度的情况下,大大提高了工业化生产的适用性和安全性。
USPTO Abstract
本发明提供一种巴洛沙韦中间体的制备方法。本发明使用有机醇镁和氯化镁作为反应试剂,以固体形式、稳定的醇镁试剂替换现有技术中液体形式的、易失活、易燃的格氏试剂,在保证反应的效率及产品纯度的情况下,大大提高了工业化生产的适用性和安全性。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.